Zydus Cadila, An Innovative, Global Pharmaceutical Company, Has Received Tentative Approval From The Us Fda To Market Droxidopa Capsules, (Us Rld: Northera) In The Strengths Of 100 Mg, 200 Mg, And 300 Mg.Droxidopa Is Used To Treat Symptoms Of Low Blood Pressure When Standing, Caused By A Certain Medical Condition (Neurogenic Orthostatic Hypotension-Noh). This Medication Can Lessen Symptoms Of Low Blood Pressure When Standing (Orthostatic Hypotension), Such As Dizziness And Lightheadedness.The Drug Will Be Manufactured At The Group&Rsquo;S Manufacturing Facility At Sez, Ahmedabad.The Group Now Has 290 Approvals And Has So Far Filed Over 386 Andas Since The Commencement Of The Filing Process In Fy 2003-04.Zydus Cadila Is An Innovative, Global Pharmaceutical Company That Discovers, Develops, Manufactures And Markets A Broad Range Of Healthcare Therapies. The Group Employs Nearly 25,000 People Worldwide And Is Dedicated To Creating Healthier Communities Globally.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!